These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 29798826)
21. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death. Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles. El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines. Willemann C; Grünert R; Bednarski PJ; Troschütz R Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationship study of 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives as anticancer agents. Selvam TP; Karthick V; Kumar PV; Ali MA Drug Discov Ther; 2012 Aug; 6(4):198-204. PubMed ID: 23006990 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors. Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754 [TBL] [Abstract][Full Text] [Related]
26. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives. Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569 [TBL] [Abstract][Full Text] [Related]
27. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies. Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel ethyl 2,4-disubstituted 8-(trifluoromethyl)pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-9-carboxylate derivatives as promising anticancer agents. Ravi Kumar N; Poornachandra Y; Krishna Swaroop D; Jitender Dev G; Ganesh Kumar C; Narsaiah B Bioorg Med Chem Lett; 2016 Nov; 26(21):5203-5206. PubMed ID: 27720296 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
30. Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach. Gundla R; Kazemi R; Sanam R; Muttineni R; Sarma JA; Dayam R; Neamati N J Med Chem; 2008 Jun; 51(12):3367-77. PubMed ID: 18500794 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and anticancer activity of some pyrido[2,3- Abbas SE; George RF; Samir EM; Aref MM; Abdel-Aziz HA Future Med Chem; 2019 Sep; 11(18):2395-2414. PubMed ID: 31544523 [No Abstract] [Full Text] [Related]
32. Synthesis and evaluation of glycosidase inhibitory activity of octahydro-2H-pyrido[1,2-a]pyrimidine and octahydro-imidazo[1,2-a]pyridine bicyclic diazasugars. Dhavale DD; Matin MM; Sharma T; Sabharwal SG Bioorg Med Chem; 2004 Aug; 12(15):4039-44. PubMed ID: 15246081 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticancer activity of some novel fused pyridine ring system. Elansary AK; Moneer AA; Kadry HH; Gedawy EM Arch Pharm Res; 2012 Nov; 35(11):1909-17. PubMed ID: 23212632 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and antitumor evaluation of novel 4-anilino-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate derivatives as potential EGFR inhibitors. Zhang D; Yan Y; Jin G; Liu B; Ma X; Han D; Jia X Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800110. PubMed ID: 30048007 [TBL] [Abstract][Full Text] [Related]
35. Efficient synthesis and biological evaluation of some 2,4-diamino-furo[2,3-d]pyrimidine derivatives. Hu YG; Wang Y; Du SM; Chen XB; Ding MW Bioorg Med Chem Lett; 2010 Nov; 20(21):6188-90. PubMed ID: 20850310 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors. Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675 [TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin. Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines. Poreba K; Wietrzyk J; Opolski A Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide. Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and anticancer activity of some new pyrazolo[3,4-d]pyrimidin-4-one derivatives. Abdellatif KR; Abdelall EK; Abdelgawad MA; Ahmed RR; Bakr RB Molecules; 2014 Mar; 19(3):3297-309. PubMed ID: 24647032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]